Latest Breaking News On - Nitai kerem - Page 1 : comparemela.com

NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing treatments for severe neurodegenerative diseases, today announced scientific presentations at three upcoming conferences.

United statesNitai keremShiran zimriFerenc tracikResearch symposiumInternational symposiumDrug administrationCompany phaseEuropean medicines agencySociety of neuroscienceNeurosense therapeutics ltdScientific project managerBiomarker driven approachStudying amyotrophic lateral sclerosisChief medical officerOrphan drug designation